Page last updated: 2024-08-21

nandrolone and HIV Wasting Syndrome

nandrolone has been researched along with HIV Wasting Syndrome in 15 studies

Research

Studies (15)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	6 (40.00)	18.2507
2000's	9 (60.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Rajadhyaksha, GC; Ray, SK; Saha, B	1
Huff, B	1
James, JS	1
Alston-Smith, B; Clark, RA; Currier, JS; Delvers, TB; Liu, T; Mulligan, K; Sattler, FR; Zackin, R	1
Beck, K; Bhasin, S; Geurts, P; Harms, MK; Mac, P; Padero, M; Sattler, F; Schroeder, ET; Singh, AB; Storer, TW; Willemsen, A; Woodhouse, LJ; Yarasheski, KE	1
Bretón, I; Camblor, M; Cuerda, C; García, P; Miralles, P; Zugasti, A	1
Aiuti, F; Batterham, MJ; Bloch, M; Danner, SA; Falleiros Carvalho, LH; Gatell, J; Gazzard, B; Geurts, TB; Gold, J; Harms, MK; Helmyr, PM; Horban, A; Lee, C; Panos, G; Phanuphak, P; Pinchera, A; Prasithsirikul, W; Rekers, H; Silva de Mendonça, J	1
Brewer, RB; Carson, JA; Dudgeon, WD; Durstine, JL; Hand, GA; Phillips, KD	1
Allen, BJ; Bodsworth, NJ; Finlayson, R; Furner, VL; Gold, J; High, HA; Li, Y; Michelmore, H; Oliver, CJ	1
Mulligan, K; Muurahainen, N	1
Barbieri, T; Christiansen, M; Hellerstein, M; Hoh, R; King, J; Neese, R; Sathyan, G; Skowronski, R; Strawford, A; Van Loan, M	1
Azen, S; Briggs, W; Dube, MP; Horton, R; Jaque, SV; Martinez, C; Olson, C; Sattler, FR; Schroeder, ET	1
Hellerstein, M; Jacob, M; Strawford, A; Van Loan, MD	1
Corcoran, C; Grinspoon, S	1
Batterham, MJ; Garsia, R	1

Reviews

2 review(s) available for nandrolone and HIV Wasting Syndrome

Article	Year
Counteracting muscle wasting in HIV-infected individuals. HIV medicine, 2006, Volume: 7, Issue:5 Topics: Cytokines; Exercise Therapy; Growth Hormone; HIV Infections; HIV Wasting Syndrome; Hormone Replacement Therapy; Humans; Insulin-Like Growth Factor I; Malnutrition; Muscular Atrophy; Nandrolone; Nandrolone Decanoate; Testosterone	2006
Clinical trials update in human immunodeficiency virus wasting. Seminars in oncology, 1998, Volume: 25, Issue:2 Suppl 6 Topics: Anabolic Agents; Appetite Stimulants; Dietary Supplements; HIV Wasting Syndrome; Humans; Megestrol Acetate; Nandrolone; Nandrolone Decanoate; Randomized Controlled Trials as Topic; Testosterone; Triglycerides	1998

Trials

9 trial(s) available for nandrolone and HIV Wasting Syndrome

Article	Year
Beneficial effects of nandrolone decanoate in wasting associated with HIV. Journal of the Indian Medical Association, 2009, Volume: 107, Issue:5 Topics: Adolescent; Adult; Aged; Anabolic Agents; Analysis of Variance; HIV Wasting Syndrome; Humans; India; Male; Middle Aged; Nandrolone; Nandrolone Decanoate; Prospective Studies; Treatment Outcome	2009
Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial. Archives of internal medicine, 2005, Mar-14, Volume: 165, Issue:5 Topics: Adult; Anabolic Agents; Blood Chemical Analysis; Body Mass Index; Body Weight; Double-Blind Method; Female; Hematologic Tests; HIV Wasting Syndrome; Hormones; Humans; Injections, Intramuscular; Nandrolone; Nandrolone Decanoate; Nutritional Status; Placebo Effect; Safety; Treatment Outcome	2005
A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment. The Journal of clinical endocrinology and metabolism, 2005, Volume: 90, Issue:8 Topics: Adipose Tissue; Adult; Anabolic Agents; Appetite; Blood Glucose; Body Composition; Gonadal Steroid Hormones; HIV Wasting Syndrome; Human Growth Hormone; Humans; Insulin Resistance; Male; Middle Aged; Muscle, Skeletal; Nandrolone; Nandrolone Decanoate; Physical Endurance; Placebos; Quality of Life; Severity of Illness Index; Sexuality; Weight Loss	2005
Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting. HIV medicine, 2006, Volume: 7, Issue:3 Topics: Adult; Anabolic Agents; Analysis of Variance; Body Mass Index; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Electric Impedance; HIV Wasting Syndrome; HIV-1; Humans; Male; Middle Aged; Nandrolone; Nandrolone Decanoate; Testosterone; Treatment Outcome	2006
Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection. AIDS (London, England), 1996, Volume: 10, Issue:7 Topics: Acquired Immunodeficiency Syndrome; Adult; Anthropometry; Body Mass Index; Body Weight; CD4 Lymphocyte Count; Dietary Fats; HIV Infections; HIV Wasting Syndrome; Humans; Male; Middle Aged; Nandrolone; Nandrolone Decanoate; Nitrogen; Quality of Life; Surveys and Questionnaires	1996
Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1999, Feb-01, Volume: 20, Issue:2 Topics: Adult; Anabolic Agents; Basal Metabolism; Body Composition; Double-Blind Method; Drug Tolerance; Exercise Test; Follicle Stimulating Hormone; HIV Wasting Syndrome; Humans; Hypogonadism; Luteinizing Hormone; Male; Middle Aged; Nandrolone; Nandrolone Decanoate; Nitrogen; Oxygen Consumption; Testosterone; Weight Gain	1999
Effects of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus. The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:4 Topics: Adult; Anabolic Agents; Body Composition; Energy Intake; Exercise; HIV Wasting Syndrome; Humans; Male; Middle Aged; Muscles; Nandrolone; Nandrolone Decanoate	1999
Monitoring changes in fat-free mass in HIV-positive men with hypotestosteronemia and AIDS wasting syndrome treated with gonadal hormone replacement therapy. AIDS (London, England), 1999, Feb-04, Volume: 13, Issue:2 Topics: Anabolic Agents; Body Composition; Double-Blind Method; HIV Wasting Syndrome; Hormone Replacement Therapy; Humans; Male; Nandrolone; Nandrolone Decanoate; Testosterone	1999
A comparison of megestrol acetate, nandrolone decanoate and dietary counselling for HIV associated weight loss. International journal of andrology, 2001, Volume: 24, Issue:4 Topics: Adult; Anabolic Agents; Appetite; Counseling; Eating; HIV Wasting Syndrome; Humans; Male; Megestrol Acetate; Middle Aged; Nandrolone; Nandrolone Decanoate; Prospective Studies; Weight Loss	2001

Other Studies

4 other study(ies) available for nandrolone and HIV Wasting Syndrome

Article	Year
Treatment for HIV wasting withdrawn. GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 2002, Volume: 16, Issue:6 Topics: HIV Wasting Syndrome; Humans; Nandrolone; Nandrolone Decanoate; United States; United States Food and Drug Administration	2002
Nandrolone (Deca Durabolin) disappears in U.S., generic may return in July. AIDS treatment news, 2002, Jun-28, Issue:381 Topics: Drugs, Generic; HIV Wasting Syndrome; Humans; Nandrolone; United States	2002
Treatment with nandrolone decanoate and megestrol acetate in HIV-infected men. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 2005, Volume: 20, Issue:1 Topics: Adult; Anabolic Agents; Anthropometry; Appetite Stimulants; Drug Therapy, Combination; HIV Infections; HIV Wasting Syndrome; Humans; Male; Megestrol Acetate; Muscle, Skeletal; Nandrolone; Nandrolone Decanoate; Quality of Life; Safety; Testosterone; Treatment Outcome; Weight Gain	2005
The use of testosterone in the AIDS wasting syndrome. AIDS clinical care, 1999, Volume: 11, Issue:4 Topics: Anabolic Agents; Body Composition; Female; HIV Wasting Syndrome; Humans; Hypogonadism; Male; Nandrolone; Oxandrolone; Quality of Life; Testosterone	1999